Racial and ethnic estimates of Alzheimer's disease and related dementias in the United States (2015–2060) in adults aged ≥65 years
Corresponding Author
Kevin A. Matthews
Division of Population Health, National Center for Chronic Disease Prevention and Health Promotion, CDC, Atlanta, GA, USA
Corresponding author. Tel.: +1 7704888124; Fax: +1 7704885965.
E-mail address: [email protected]
Search for more papers by this authorWei Xu
Department of Geography, University of Wisconsin-Milwaukee, Milwaukee, WI, USA
Search for more papers by this authorAnne H. Gaglioti
National Center for Primary Care, Department of Family Medicine, Morehouse School of Medicine, Atlanta, GA, USA
Search for more papers by this authorJames B. Holt
Division of Population Health, National Center for Chronic Disease Prevention and Health Promotion, CDC, Atlanta, GA, USA
Search for more papers by this authorJanet B. Croft
Division of Population Health, National Center for Chronic Disease Prevention and Health Promotion, CDC, Atlanta, GA, USA
Search for more papers by this authorDominic Mack
National Center for Primary Care, Department of Family Medicine, Morehouse School of Medicine, Atlanta, GA, USA
Search for more papers by this authorLisa C. McGuire
Division of Population Health, National Center for Chronic Disease Prevention and Health Promotion, CDC, Atlanta, GA, USA
Search for more papers by this authorCorresponding Author
Kevin A. Matthews
Division of Population Health, National Center for Chronic Disease Prevention and Health Promotion, CDC, Atlanta, GA, USA
Corresponding author. Tel.: +1 7704888124; Fax: +1 7704885965.
E-mail address: [email protected]
Search for more papers by this authorWei Xu
Department of Geography, University of Wisconsin-Milwaukee, Milwaukee, WI, USA
Search for more papers by this authorAnne H. Gaglioti
National Center for Primary Care, Department of Family Medicine, Morehouse School of Medicine, Atlanta, GA, USA
Search for more papers by this authorJames B. Holt
Division of Population Health, National Center for Chronic Disease Prevention and Health Promotion, CDC, Atlanta, GA, USA
Search for more papers by this authorJanet B. Croft
Division of Population Health, National Center for Chronic Disease Prevention and Health Promotion, CDC, Atlanta, GA, USA
Search for more papers by this authorDominic Mack
National Center for Primary Care, Department of Family Medicine, Morehouse School of Medicine, Atlanta, GA, USA
Search for more papers by this authorLisa C. McGuire
Division of Population Health, National Center for Chronic Disease Prevention and Health Promotion, CDC, Atlanta, GA, USA
Search for more papers by this authorAbstract
Introduction
Alzheimer's disease and related dementias (ADRD) cause a high burden of morbidity and mortality in the United States. Age, race, and ethnicity are important risk factors for ADRD.
Methods
We estimated the future US burden of ADRD by age, sex, and race and ethnicity by applying subgroup-specific prevalence among Medicare Fee-for-Service beneficiaries aged ≥65 years in 2014 to subgroup-specific population estimates for 2014 and population projection data from the United States Census Bureau for 2015 to 2060.
Results
The burden of ADRD in 2014 was an estimated 5.0 million adults aged ≥65 years or 1.6% of the population, and there are significant disparities in ADRD prevalence among population subgroups defined by race and ethnicity. ADRD burden will double to 3.3% by 2060 when 13.9 million Americans are projected to have the disease.
Discussion
These estimates can be used to guide planning and interventions related to caring for the ADRD population and supporting caregivers.
Supporting Information
Filename | Description |
---|---|
alzjjalz2018063063-sup-0001.docxapplication/docx, 166.8 KB | Supplementary Appendix 1 |
Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
References
- [1]2016 Alzheimer's disease facts and figures. Alzheimers Dement. 12: 2016; 459–509
- [2]R Brookmeyer, DA Evans, L Hebert, KM Langa, SG Heeringa, BL Plassman, et al. National estimates of the prevalence of Alzheimer's disease in the United States. Alzheimers Dement. 7: 2011; 61–73
- [3]LE Hebert, J Weuve, PA Scherr, DA Evans. Alzheimer disease in the United States (2010–2050) estimated using the 2010 census. Neurology. 80: 2013; 1778–1783
- [4]WA Rocca, RC Petersen, DS Knopman, LE Hebert, DA Evans, KS Hall, et al. Trends in the incidence and prevalence of Alzheimer's disease, dementia, and cognitive impairment in the United States. Alzheimers Dement. 7: 2011; 80–93
- [5]R Brookmeyer, N Abdalla, CH Kawas, MM Corrada. Forecasting the prevalence of preclinical and clinical Alzheimer's disease in the United States. Alzheimer's Demen. 14: 2018; 121–129
- [6] The Healthy Brain Initiative: The Public Health Road Map for State and National Partnerships, 2013–2018. 2013; Alzheimer's Association: Chicago, IL
- [7]Mirel LB, Wheatcroft G, Parker JD, Makuc D. Health Characteristics of Medicare Traditional Fee-for-Service and Medicare Advantage enrollees: 1999-2004 National Health and Nutrition Examination Survey linked to 2007 Medicare Data. (US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics, 2012).
- [8]E Byhoff, JA Harris, JZ Ayanian. Characteristics of decedents in Medicare Advantage and traditional Medicare. JAMA Intern Med. 176: 2016; 1020–1023
- [9]EA Miller, SL Decker, JD Parker. Characteristics of Medicare advantage and Fee-for-Service (FFS) beneficiaries upon enrollment in Medicare at Age 65. J Ambul Care Manag. 39: 2016; 231–241
- [10]G Jacobson, A Damico, T Neuman, M Gold. Medicare Advantage 2015 Spotlight: Enrollment Market Update, Available at:http://kff.org/medicare/issue-brief/medicare-advantage-2015-spotlight-enrollment-market-update/ 2015, Accessed November 2017
- [11]DH Taylor Jr, T Østbye, KM Langa, D Weir, BL Plassman. The accuracy of Medicare claims as an epidemiological tool: The case of dementia revisited. J Alzheimers Dis. 17: 2009; 807
- [12]BL Plassman, KM Langa, GG Fisher, SG Heeringa, DR Weir, MB Ofstedal, et al. Prevalence of dementia in the United States: The aging, demographics, and memory study. Neuroepidemiology. 29: 2007; 125–132
- [13]Ortman JM, Velkoff VA, Hogan H. An Aging Nation: The Older Population in the United States. (United States Census Bureau, Economics and Statistics Administration, US Department of Commerce, 2014).
- [14]S Colby, J Ortman. Projections of the size and composition of the US population: 2014 to 2060 (Current Population Reports, P25-1143). 2017; US Census Bureau: Washington, DC, Accessed November 2017
- [15]R Bernstein. Census Bureau projections show a slower growing, older, more diverse nation a half century from now(Press Release, CB12-243)2015; US Census Bureau: Washington, DC, Accessed March 2016
- [16]RA Goodman, KA Lochner, M Thambisetty, TS Wingo, SF Posner, SM Ling. Prevalence of dementia subtypes in United States Medicare Fee-for-Service (FFS) beneficiaries, 2011–2013. Alzheimers Dement. 13: 2017; 28–37
- [17]K Steenland, FC Goldstein, A Levey, W Wharton. A meta-analysis of Alzheimer's disease incidence and prevalence comparing African-Americans and Caucasians. J Alzheimer's Dis. 50: 2015; 71–76
- [18]ER Mayeda, MM Glymour, CP Quesenberry, RA Whitmer. Inequalities in dementia incidence between six racial and ethnic groups over 14 years. Alzheimer's Demen. 12: 2016; 216–224
- [19]R Samper-Ternent, YF Kuo, LA Ray, KJ Ottenbacher, KS Markides, S Al Snih. Prevalence of health conditions and predictors of mortality in oldest old Mexican Americans and non-Hispanic whites. J Am Med Directors Assoc. 13: 2012; 254–259
- [20]MN Haan, DM Mungas, HM Gonzalez, TA Ortiz, A Acharya, WJ Jagust. Prevalence of dementia in older Latinos: The influence of type 2 diabetes mellitus, stroke and genetic factors. J Am Geriatr Soc. 51: 2003; 169–177
- [21]BJ Gurland, DE Wilder, R Lantigua, Y Stern, J Chen, EH Killeffer, et al. Rates of dementia in three ethnoracial groups. Int J Geriatr Psychiatry. 14: 1999; 481–493
10.1002/(SICI)1099-1166(199906)14:6<481::AID-GPS959>3.0.CO;2-5 CASPubMedWeb of Science®Google Scholar
- [22]PC Clark, NG Kutner, FC Goldstein, S Peterson-Hazen, V Garner, R Zhang, et al. Impediments to timely diagnosis of Alzheimer's disease in African Americans. J Am Geriatr Soc. 53: 2005; 2012–2017
- [23]LJ Fitten, F Ortiz, M Pontón. Frequency of Alzheimer's disease and other dementias in a community outreach sample of Hispanics. J Am Geriatr Soc. 49: 2001; 1301–1308
- [24]A Solomon, F Mangialasche, E Richard, S Andrieu, DA Bennett, M Breteler, et al. Advances in the prevention of Alzheimer's disease and dementia. J Intern Med. 275: 2014; 229–250
- [25] Medicare Beneficiary Characteristics. 2014; Centers for Medicare and Medicaid Services: Baltimore, MD
- [26] Unpublished tabular data from the Office of Enterprise Data and Analytics. 2016; Centers for Medicare and Medicaid Services: Baltimore, MD
- [27]R Newcomer, T Clay, JS Luxenberg, RH Miller. Misclassification and selection bias when identifying Alzheimer's disease solely from Medicare claims records. J Am Geriatr Soc. 47: 1999; 215–219
- [28]T Erkinjuntti, T Østbye, R Steenhuis, V Hachinski. The effect of different diagnostic criteria on the prevalence of dementia. N Engl J Med. 337: 1997; 1667–1674
- [29]AL Sosa-Ortiz, I Acosta-Castillo, MJ Prince. Epidemiology of dementias and Alzheimer's disease. Arch Med Res. 43: 2012; 600–608
- [30] US Department of Health and Human Services. National Plan to Address Alzheimer's Disease, Available at:https://aspe.hhs.gov/national-plan-address-alzheimer%E2%80%99s-disease-2015-update 2016, Accessed July 2018
- [31]CB Cordell, S Borson, M Boustani, J Chodosh, D Reuben, J Verghese, et al. Alzheimer's Association recommendations for operationalizing the detection of cognitive impairment during the Medicare Annual Wellness Visit in a primary care setting. Alzheimer's Demen. 9: 2013; 141–150
- [32]BE Hamilton, JA Martin, MJK Osterman, AK Driscoll, LM Roseen. Births: Provisional Data for 2016. (Vital Statistics Rapid Release; No 2). 2017; National Center for Health Statistics: Bethesda, MD
- [33]Older American 2012: Key Indicators of Well-Being. Washington, DC: Federal Interagency Forum on Aging-Related Statistics. US Government Printing Office; 2012.
- [34]D Redfoot, L Feinberg, A Houser. The Aging of the Baby Boom and the Growing Care Gap: A Look at Future Declines in the Availability of Family Caregivers. 2013; AARP Public Policy Institute: Washington, DC
- [35]PP Vitaliano, J Zhang, JM Scanlan. Is caregiving hazardous to one's physical health? A meta-analysis. Psychol Bull. 129: 2003; 946
- [36]S Sörensen, P Duberstein, D Gill, M Pinquart. Dementia care: Mental health effects, intervention strategies, and clinical implications. Lancet Neurol. 5: 2006; 961–973
- [37]R Schulz, SR Beach. Caregiving as a risk factor for mortality: The Caregiver Health Effects Study. JAMA. 282: 1999; 2215–2219
- [38]Revisions to payment policies under the physician fee schedule and other revisions to Part B for CY 2017. Fed Regist. 2016: 2016; 80170
- [39]MD Douglas, DE Dawes, KB Holden, D Mack. Missed policy opportunities to advance health equity: Missed policy opportunities to advance health equity by recording demographic data in electronic health records. Am J Public Health. 105: 2015; S380
- [40]X Meng, C D'Arcy. Education and dementia in the context of the cognitive reserve hypothesis: A systematic review with meta-analyses and qualitative analyses. PLoS One. 7: 2012; e38268
- [41]M Baumgart, HM Snyder, MC Carrillo, S Fazio, H Kim, H Johns. Summary of the evidence on modifiable risk factors for cognitive decline and dementia: A population-based perspective. Alzheimers DemenT. 11: 2015; 718–726
- [42]K Manton, X Gu, S Ukraintseva. Declining prevalence of dementia in the US elderly population. Adv Gerontol. 16: 2005; 30–37
- [43]M Prince, GC Ali, M Guerchet, AM Prina, E Albanese, YT Wu. Recent global trends in the prevalence and incidence of dementia, and survival with dementia. Alzheimer's Res Ther. 8: 2016; 23
- [44]KM Langa, EB Larson, JH Karlawish, DM Cutler, MU Kabeto, SY Kim, et al. Trends in the prevalence and mortality of cognitive impairment in the United States: Is there evidence of a compression of cognitive morbidity?. Alzheimer's Demen. 4: 2008; 134–144
- [45]YT Wu, AS Beiser, MM Breteler, L Fratiglioni, C Helmer, HC Hendrie, et al. The changing prevalence and incidence of dementia over time–current evidence. Nature Rev Neurol. 13: 2017; 327